about
Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cellsReal-time visualization and quantitation of vascular permeability in vivo: implications for drug deliveryThe chick embryo as an expanding experimental model for cancer and cardiovascular researchThe inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151.Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles.Directional cell movement through tissues is controlled by exosome secretionGenetic reprogramming of tumor cells by zinc finger transcription factorsSensitivity of cancer cells to truncated diphtheria toxin.ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to boneSubtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.Flipping the switch: integrin switching provides metastatic competenceThe DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel.A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology.Targeting tumor cell motility to prevent metastasis.CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling.Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancerViral nanoparticles as tools for intravital vascular imaging.Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.Magnetically attachable stencils and the non-destructive analysis of the contribution made by the underlying matrix to cell migration.Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells.Lack of specificity of endoglin expression for tumor blood vessels.Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis.Launching an academic research careerDetection of multiple fibronectin isoforms in fetal fibroblast monolayer culture: a novel method for the qualitative and quantitative detection of multiple antigensModulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166Myeloid cell-derived TGF-beta signaling regulates ECM deposition in mammary carcinoma via adenosine-dependent mechanismsA live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells
P50
Q22000749-6F886912-CE4A-4A10-999F-F3911AEB0A9CQ24534541-B6B15A42-F98B-4D65-965D-802F219D2D67Q27306235-06C44FD7-E3DB-4078-8579-AF1D60A37A75Q28655771-9B2400D0-AE7B-4E5B-8455-C40FD59FC020Q30499283-4408F8C6-9106-4EF9-95AC-F3FECD5369C5Q30503845-4EFD66A7-5A9F-4161-B97F-FADBC84DEEC3Q30650966-E5E66FC2-8DE7-4BF5-A4D0-663EE970B8C1Q33221141-DA0487C7-324E-4ED2-9F37-931A6DECE9C0Q33576864-3A408848-B4A3-405C-8CC7-A925862B87EAQ34112011-E48DE6E8-B4DB-414E-9A79-CCDE3168CED5Q34186414-C7A2171A-4648-4DFE-85A8-F72FEB964678Q34402680-F947D719-ADF2-4D59-B2BE-7E3C4DE6CFB7Q34564440-3E2CB0E4-A6A3-493C-BC19-777EA42E963DQ34899860-54FC3066-2FD7-48AA-B973-EC2486F77CD2Q35095152-0D9A712B-23A2-4922-9379-64CC852E170FQ36118896-C78CACF1-5026-4A52-9434-1AA431BFA8E8Q36547455-13FD8F20-B3C0-4C2D-B3BD-B8177DABB2A4Q36876252-E6AA73F6-64CC-42D2-A0CB-3082F7545FE5Q37626182-F3877DB6-64AE-46BD-8FC0-46CE8D9E7FA6Q39173902-29F15865-A915-4160-B54E-6F010075531EQ39287153-DC792268-0FAE-4FE8-A008-D501B1430632Q40345030-1507B52F-12A9-44E9-818D-B16F9CA9A060Q40370860-F9A5BC8D-5CC3-499D-AFBF-3D5E7A23E7F9Q40763090-91930447-0EE2-40C0-BF4A-ED6B6B47D7F5Q49913406-48E62074-687F-4A14-A5AB-6D6A15E31399Q55315550-7181A6B9-2827-47D8-9DA0-84AEEE7D21A0Q57204460-A7C07FEF-6792-456C-A70C-A4050DB2FD50Q57204464-A0BAEE5C-CD5E-4CDA-8424-115BDB14D6E4Q91694988-44CEE19F-D5CB-4FFE-B2CF-F75202ACD474Q92091662-83BEF40A-D8B4-4E9B-9716-A360871E5C95Q94461590-BB46A4AC-7274-42A4-9305-E04DE242A385
P50
description
hulumtues
@sq
pathologist
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andries Zijlstra
@ast
Andries Zijlstra
@en
Andries Zijlstra
@es
Andries Zijlstra
@nl
Andries Zijlstra
@sl
type
label
Andries Zijlstra
@ast
Andries Zijlstra
@en
Andries Zijlstra
@es
Andries Zijlstra
@nl
Andries Zijlstra
@sl
altLabel
Andrew Zijlstra
@en
Andrew Zylstra
@en
prefLabel
Andries Zijlstra
@ast
Andries Zijlstra
@en
Andries Zijlstra
@es
Andries Zijlstra
@nl
Andries Zijlstra
@sl
P1053
G-4564-2013
P106
P21
P31
P3829
P496
0000-0001-8460-8803